CTRI/2021/02/031017尚未招募未知
Therapeutic Role of Ripasudil 0.4 % for corneal endothelial protection in phacoemulsification of hard cataracts - A randomized controlled trial
Srikiran eye institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •senile cataract patients with grade 3 and above(LOCS 3 Grading) ,willing to participate in study
排除标准
- •pregnent and lactating mothers ,complicated cataracts , one eyed patients ,intra operative complications which may influence the outcome
研究者
相似试验
招募中
不适用
Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgeryglaucomaJPRN-UMIN000042504Hiroshima University Hospital100
已完成
不适用
Evaluation for topical use of ripasudil as ophthalmic solution.GlaucomaJPRN-UMIN000046037Kawasaki Medical School26
已完成
不适用
Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under.glaucomaJPRN-UMIN000030742Yotsuya Shirato Ophthalmology Clinic30
已完成
不适用
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrateJPRN-UMIN000044345Teikyo University School of Medicine100
招募中
不适用
Intraocular pressure-lowering effect of ripasudil hydrochloride hydrate for glaucomaglaucomaJPRN-UMIN000046124Teikyo University School of Medicine, Department of Ophthalmology20